Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-45,900
Closed -$3.95M 1082
2022
Q3
$3.95M Buy
45,900
+31,700
+223% +$2.83M 0.14% 187
2022
Q2
$1.29M Sell
14,200
-26,800
-65% -$2.38M 0.05% 464
2022
Q1
$3.36M Sell
41,000
-34,900
-46% -$2.75M 0.12% 203
2021
Q4
$5.82M Buy
75,900
+47,900
+171% +$3.82M 0.2% 95
2021
Q3
$2.1M Sell
28,000
-34,200
-55% -$2.6M 0.07% 443
2021
Q2
$4.84M Buy
62,200
+28,769
+86% +$2.14M 0.16% 129
2021
Q1
$2.46M Sell
33,431
-10,585
-24% -$781K 0.08% 328
2020
Q4
$3.44M Buy
+44,016
New +$3.37M 0.16% 141

Other funds holding MRK

Point72 Hong Kong's MRK Position: Q4 2024 in Review

Point72 Hong Kong sold out of Merck (MRK) in Q4 2024, closing a stake of 14,765 shares — an estimated $1.68M sold.

Point72 Hong Kong first reported a position in MRK in Q3 2014 and held it in 22 quarters. The position peaked at $15.5M in Q2 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Point72 Hong Kong reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 14,765 Merck shares in Q4 2024, an estimated $1.68M.
  • Point72 Hong Kong first reported a position in Merck in Q3 2014 and held it in 22 quarters.
  • Point72 Hong Kong's Merck position peaked at $15.5M in Q2 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Point72 Hong Kong's 13F filing for Q4 2024, filed 14 Feb 2025.